Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine for Cognitive Outcome in Moderate TBI
NCT01343862Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Aug 2011
- Primary completion
- May 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in traumatic brain injury (TBI) comparing D- Cycloserine with Placebo (2 arms). Primary endpoint: Battery of neuropsychological tests at 6 months. Status: unknown.
02
Drugs
d-cycloserine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01343862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01343862.